Tag: Health Care

Displaying 101 - 120 of 1044 results.

Pages

In testimony before Congress today, the Federal Trade Commission outlined its work to protect consumers in the growing area of health information technology.
The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the Third Circuit urging the court to correct four legal errors in a district court’s antitrust analysis of an alleged reverse-payment agreement involving brand-name pharmaceutical company GlaxoSmithKline and...
Brief of the Federal Trade Commission arguing that the district court committed multiple legal errors that should be corrected on appeal. The district court erroneously concluded that a reverse-payment settlement that allowed the underlying patent litigation to continue, while the...
Federal Trade Commission staff submitted written comments on the competitive impact of provisions in proposed legislation in West Virginia that would provide for  “cooperative agreements” between health care providers, and provisions purporting to confer “exemptions” from federal antitrust laws on...
The FTC issued an administrative complaint alleging that the proposed merger of Advocate Health Care Network and NorthShore University HealthSystem will create the largest hospital system in the North Shore area of Chicago.  According to the complaint, the combined entity would...
Drug manufacturer Hikma Pharmaceuticals PLC agreed to sell the rights and assets for two generic drugs, and relinquish its U.S. marketing rights to a third generic drug, in order to settle FTC charges that its proposed $2 billion acquisition of Roxane would likely be anticompetitive....
There is a basic but important difference between antitrust cases brought by the government and those brought by private parties: All plaintiffs, including government enforcers like the FTC, must prove an antitrust violation, which requires showing harm to competition. But private...
Generic drug marketer Hikma Pharmaceuticals PLC agreed to divest its rights and interests in five generic injectable pharmaceuticals to settle charges that its $5 million acquisition of the rights to various drug products and related assets from Ben Venue Laboratories, Inc. would...
Generic drug manufacturers Lupin Ltd. and Gavis Pharmaceuticals LLC agreed to sell the rights and assets for two generic drugs, in order to settle FTC charges that Lupin’s proposed $850 million acquisition of Gavis would likely be anticompetitive.The merger would have combined two of...
In response to a request by Massachusetts State Representative Bradley H. Jones, the Federal Trade Commission and the Department of Justice’s Antitrust Division have submitted a statement encouraging the Massachusetts legislature to consider expanding the services that optometrists can provide to...
Federal Trade Commission staff submitted written comments on the competitive impact of a legislative proposal to modify the supervision requirements imposed on Advanced Practice Registered Nurses (APRNs) in West Virginia, permitting some APRNs, under limited conditions, to write prescriptions...
FTC staff submitted a comment, in response to a request from Georgia State Senator Valencia Seay, regarding proposed legislation that would broaden the types of settings under which Georgia dental hygienists are allowed to provide preventive care without direct on-site supervision by...
Federal Trade Commission staff submitted a comment regarding proposed legislation that would broaden the types of settings under which Georgia dental hygienists are allowed to provide preventive care without the direct supervision of a dentist. The comments are in response to a request from Georgia...
Since 2004, brand-name and generic drug manufacturers have filed certain agreements with the FTC and DOJ as required by the Medicare Prescription Drug, Improvement and Modernization Act (also known as MMA filings).
In response to a request by South Carolina Governor Nikki Haley, the Federal Trade Commission and the Department of Justice’s Antitrust Division (the agencies) have submitted a statement regarding the competitive implications of certificate-of-need (CON) laws and South Carolina House Bill 3250 – a...
Henry Schein Practice Solutions, Inc. (“Schein”), the provider of leading office management software for dental practices, will pay $250,000 to settle Federal Trade Commission charges it falsely advertised the level of encryption it provided to protect patient data.

Pages